{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:03:31Z","timestamp":1793365411697,"version":"4.5.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0610"],"award-info":[{"award-number":["2024NSFSC0610"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0622"],"award-info":[{"award-number":["2022YFS0622"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024LZXNYDJ102"],"award-info":[{"award-number":["2024LZXNYDJ102"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neuropharm.2025.110439","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T09:58:51Z","timestamp":1743587931000},"page":"110439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson's disease therapy"],"prefix":"10.1016","volume":"274","author":[{"given":"Wenjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Rosalind","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qulian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110439_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109909","article-title":"Neuro-modulatory impact of felodipine against experimentally-induced Parkinson's disease: possible contribution of PINK1-Parkin mitophagy pathway","volume":"250","author":"Abou-Hany","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110439_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051075","article-title":"PGC-1alpha is a master regulator of mitochondrial lifecycle and ROS stress response","volume":"12","author":"Abu Shelbayeh","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2025.110439_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1374735","article-title":"Molecular mechanisms of mitochondria-mediated ferroptosis: a potential target for antimalarial interventions","volume":"12","author":"Adegboro","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","article-title":"Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease","volume":"91","author":"Ahmed","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2025.110439_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature24637","article-title":"NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis","volume":"551","author":"Alvarez","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110439_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FBP.0000000000000342","article-title":"Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals","volume":"29","author":"Attia","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11064-020-03186-w","article-title":"Idebenone ameliorates rotenone-induced Parkinson's disease in rats through decreasing lipid peroxidation","volume":"46","author":"Avci","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2025.110439_bib8","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1073\/pnas.84.23.8478","article-title":"Iron regulates ferritin mRNA translation through a segment of its 5' untranslated region","volume":"84","author":"Aziz","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110439_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","article-title":"Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography","volume":"45","author":"Becker","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2025.110439_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2025.110439_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of alpha-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110439_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110439_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fncel.2016.00024","article-title":"Alterations in mitochondrial quality control in Alzheimer's disease","volume":"10","author":"Cai","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110439_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuint.2011.05.006","article-title":"Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease","volume":"59","author":"Carroll","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2025.110439_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153964","article-title":"Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway","volume":"99","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2025.110439_bib16","article-title":"PGC-1alpha-Mediated mitochondrial quality control: molecular mechanisms and implications for heart failure","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib17","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41418-021-00859-z","article-title":"Organelle-specific regulation of ferroptosis","volume":"28","author":"Chen","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2025.110439_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110439_bib19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","article-title":"Pathological structural conversion of alpha-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110439_bib20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","article-title":"Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism","volume":"104","author":"Cleren","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110439_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-024-07623-6","article-title":"Emergence of large-scale cell death through ferroptotic trigger waves","volume":"631","author":"Co","year":"2024","journal-title":"Nature"},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2025.110439_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1469-7793.2000.t01-1-00203.x","article-title":"Oxidative capacity and ageing in human muscle","volume":"526","author":"Conley","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110672","article-title":"Glucose metabolism impairment in Parkinson's disease","volume":"199","author":"Dai","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2025.110439_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001287","article-title":"alpha-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes","volume":"19","author":"Dilsizoglu Senol","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109644","article-title":"Silibinin alleviates ferroptosis of rat islet beta cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1\/parkin-mediated mitophagy","volume":"743","author":"Du","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2025.110439_bib26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","article-title":"Mitochondrial quality control in health and in Parkinson's disease","volume":"102","author":"Eldeeb","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110439_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.24294","article-title":"Mutual exacerbation of peroxisome proliferator-activated receptor gamma coactivator 1alpha deregulation and alpha-synuclein oligomerization","volume":"77","author":"Eschbach","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2022.11.029","article-title":"A novel 3-phenylglutaric acid derivative (84-B10) alleviates cisplatin-induced acute kidney injury by inhibiting mitochondrial oxidative stress-mediated ferroptosis","volume":"194","author":"Fan","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2025.110439_bib29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-010-0482-8","article-title":"Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease","volume":"118","author":"Ferrer","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2025.110439_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114724","article-title":"Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease","volume":"375","author":"Fu","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2025.110439_bib32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2025.110439_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.885500","article-title":"Mitochondrial dysfunction in Parkinson's disease: from mechanistic insights to therapy","volume":"14","author":"Gao","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110439_bib34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1021\/acschembio.8b00199","article-title":"Determination of the subcellular localization and mechanism of action of ferrostatins in suppressing ferroptosis","volume":"13","author":"Gaschler","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib35","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1021\/acschemneuro.7b00287","article-title":"MitoNEET (CISD1) knockout mice show signs of striatal mitochondrial dysfunction and a Parkinson's disease phenotype","volume":"8","author":"Geldenhuys","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110439_bib36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonzalez-Rodriguez","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110439_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.expneurol.2017.02.001","article-title":"Mitochondrial ferritin protects SH-SY5Y cells against H(2)O(2)-induced oxidative stress and modulates alpha-synuclein expression","volume":"291","author":"Guan","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib38","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate alpha-synuclein transmission in Parkinson's disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2025.110439_bib39","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1038\/s41467-023-40929-z","article-title":"PINK1 and Parkin regulate IP(3)R-mediated ER calcium release","volume":"14","author":"Ham","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110439_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3846217","article-title":"HO-1 contributes to luteolin-triggered ferroptosis in clear cell renal cell carcinoma via increasing the labile iron pool and promoting lipid peroxidation","volume":"2022","author":"Han","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2025.110439_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2008.09.069","article-title":"The coenzyme Q10 status of the brain regions of Parkinson's disease patients","volume":"447","author":"Hargreaves","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110439_bib42","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06328","article-title":"Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport","volume":"4","author":"Hashidate-Yoshida","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2025.110439_bib43","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.3685996","article-title":"Identification of the iron-responsive element for the translational regulation of human ferritin mRNA","volume":"238","author":"Hentze","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110439_bib44","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/jcbfm.2012.35","article-title":"Updated energy budgets for neural computation in the neocortex and cerebellum","volume":"32","author":"Howarth","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib45","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110439_bib46","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1096\/fj.08-128926","article-title":"Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism","volume":"23","author":"James","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110439_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","article-title":"Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease","volume":"169","author":"Janetzky","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110439_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2018.01.019","article-title":"Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis","volume":"117","author":"Jelinek","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2025.110439_bib49","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/tox.24275","article-title":"Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1\/Parkin-mediated mitophagy and AMPK\/SIRT1\/PGC1-alpha-mediated mitochondrial biogenesis","volume":"39","author":"Jhuo","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib50","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1021\/bi300382d","article-title":"Biophysical investigation of the ironome of human jurkat cells and mitochondria","volume":"51","author":"Jhurry","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2025.110439_bib51","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0183-16.2016","article-title":"Adult conditional knockout of PGC-1alpha leads to loss of dopamine neurons","volume":"3","author":"Jiang","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2025.110439_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI101994","article-title":"The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values","volume":"27","author":"Kety","year":"1948","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110439_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111679","article-title":"Ferroptosis as a major factor and therapeutic target for neuroinflammation in Parkinson's disease","volume":"9","author":"Ko","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2025.110439_bib55","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1073\/pnas.86.10.3574","article-title":"A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA","volume":"86","author":"Koeller","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110439_bib56","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/hbm.23192","article-title":"Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited","volume":"37","author":"Langley","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2025.110439_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","article-title":"Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells","volume":"15","author":"Le","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110439_bib58","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/15548627.2020.1739447","article-title":"Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2025.110439_bib59","article-title":"The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2025.110439_bib60","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.7150\/ijbs.83348","article-title":"The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110439_bib61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12906-023-03967-0","article-title":"Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson's disease via inhibiting oxidative stress and ferroptosis","volume":"23","author":"Li","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.neuropharm.2025.110439_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2022.05.024","article-title":"NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2\/Gpx4 pathway","volume":"187","author":"Li","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2025.110439_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117196","article-title":"Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease","volume":"319","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib64","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.molcel.2024.07.020","article-title":"OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response","volume":"84","author":"Liang","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2025.110439_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin protects against MPP(+)\/MPTP-Induced dopaminergic neuron death in Parkinson's disease by inhibiting ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2025.110439_bib66","doi-asserted-by":"crossref","first-page":"19924","DOI":"10.1073\/pnas.1908271116","article-title":"Redox-dependent gating of VDAC by mitoNEET","volume":"116","author":"Lipper","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110439_bib67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12929-023-00975-7","article-title":"Crosstalk between mitochondrial biogenesis and mitophagy to maintain mitochondrial homeostasis","volume":"30","author":"Liu","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2025.110439_bib68","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4103\/1673-5374.371381","article-title":"Rapamycin reverses ferroptosis by increasing autophagy in MPTP\/MPP(+)-induced models of Parkinson's disease","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neuropharm.2025.110439_bib69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12951-024-02618-x","article-title":"Cardiac-derived extracellular vesicles improve mitochondrial function to protect the heart against ischemia\/reperfusion injury by delivering ATP5a1","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib70","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.adf4154","article-title":"Autoregulatory control of mitochondrial glutathione homeostasis","volume":"382","author":"Liu","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110439_bib71","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110439_bib72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","article-title":"A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease","volume":"34","author":"Mastroberardino","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2025.110439_bib73","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41598-023-49600-5","article-title":"Striatal dopamine neurotransmission is altered in age- and region-specific manner in a Parkinson's disease transgenic mouse","volume":"14","author":"Medina-Luque","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110439_bib74","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2011.04.137","article-title":"Effect of mitochondrial complex I inhibition on Fe-S cluster protein activity","volume":"409","author":"Mena","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110439_bib75","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.18632\/aging.205062","article-title":"Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1","volume":"15","author":"Meng","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuropharm.2025.110439_bib76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","article-title":"Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease","volume":"219","author":"Meredith","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib77","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.410350212","article-title":"An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease","volume":"35","author":"Mizuno","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib78","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41531-022-00397-6","article-title":"Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology","volume":"8","author":"Navarro-Romero","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.neuropharm.2025.110439_bib79","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2017.10.024","article-title":"Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease","volume":"63","author":"Nido","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2025.110439_bib80","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.1117728","article-title":"Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS","volume":"310","author":"Nisoli","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110439_bib81","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41420-022-01199-8","article-title":"Mitochondrial event as an ultimate step in ferroptosis","volume":"8","author":"Oh","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2025.110439_bib82","doi-asserted-by":"crossref","first-page":"27829","DOI":"10.1074\/jbc.M115.682179","article-title":"Cytosolic Fe-S cluster protein maturation and iron regulation are independent of the mitochondrial erv1\/mia40 import system","volume":"290","author":"Ozer","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110439_bib83","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","article-title":"ROS production by mitochondria: function or dysfunction?","volume":"43","author":"Palma","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2025.110439_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1557","article-title":"A blood-based marker of mitochondrial DNA damage in Parkinson's disease","volume":"15","author":"Qi","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2025.110439_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116440","article-title":"Mitoglitazone ameliorates renal ischemia\/reperfusion injury by inhibiting ferroptosis via targeting mitoNEET","volume":"465","author":"Qi","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112596","article-title":"Loureirin C improves mitochondrial function by promoting NRF2 nuclear translocation to attenuate oxidative damage caused by renal ischemia-reperfusion injury","volume":"138","author":"Qi","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib87","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cbic.200600311","article-title":"Assessment of chelatable mitochondrial iron by using mitochondrion-selective fluorescent iron indicators with different iron-binding affinities","volume":"8","author":"Rauen","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.neuropharm.2025.110439_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110439_bib89","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.molcel.2023.12.008","article-title":"Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis","volume":"84","author":"Shi","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2025.110439_bib90","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/ars.2009.3018","article-title":"Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease","volume":"13","author":"Shi","year":"2010","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuropharm.2025.110439_bib91","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbadis.2012.07.009","article-title":"The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease","volume":"1832","author":"Solesio","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2025.110439_bib92","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110439_bib93","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuropharm.2025.110439_bib94","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1186\/s12967-023-04715-1","article-title":"WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis","volume":"21","author":"Tai","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuropharm.2025.110439_bib95","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/jcp.31044","article-title":"MitoNEET prevents iron overload-induced insulin resistance in H9c2 cells through regulation of mitochondrial iron","volume":"238","author":"Tam","year":"2023","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4302","article-title":"Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5","volume":"7","author":"Terzi","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2025.110439_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175133","article-title":"Therapeutic insights on ferroptosis in Parkinson's disease","volume":"930","author":"Thapa","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.freeradbiomed.2024.04.240","article-title":"Microglial gp91phox-mediated neuroinflammation and ferroptosis contributes to learning and memory deficits in rotenone-treated mice","volume":"220","author":"Tian","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2025.110439_bib99","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2354918","article-title":"Beta-hydroxybutyrate protects against cisplatin-induced renal damage via regulating ferroptosis","volume":"46","author":"Tian","year":"2024","journal-title":"Ren. Fail."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2025.110439_bib100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jnc.13696","article-title":"Molecular changes in the postmortem parkinsonian brain","volume":"139","author":"Toulorge","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110439_bib101","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1038\/s41380-023-02251-4","article-title":"Mitochondrial DNA damage triggers spread of Parkinson's disease-like pathology","volume":"28","author":"Tresse","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110439_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1267\/ahc.22-00109","article-title":"Immunohistochemical analysis of mitochondrial ferritin in the midbrain of patients with Parkinson's disease","volume":"56","author":"Tsubaki","year":"2023","journal-title":"Acta Histochem. Cytoc."},{"key":"10.1016\/j.neuropharm.2025.110439_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110148","article-title":"Astaxanthin attenuates osteoarthritis progression via inhibiting ferroptosis and regulating mitochondrial function in chondrocytes","volume":"366","author":"Wang","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2025.110439_bib104","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-021-04025-w","article-title":"SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells","volume":"599","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110439_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109870","article-title":"Hydrogen sulfide guards myoblasts from ferroptosis by inhibiting ALOX12 acetylation","volume":"78","author":"Wang","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2025.110439_bib106","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fnagi.2016.00308","article-title":"The protective role of mitochondrial ferritin on erastin-induced ferroptosis","volume":"8","author":"Wang","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110439_bib107","first-page":"1","article-title":"Oxidative stress in human aging and mitochondrial disease-consequences of defective mitochondrial respiration and impaired antioxidant enzyme system","volume":"44","author":"Wei","year":"2001","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116282","article-title":"QiShenYiQi dripping pill alleviates myocardial ischemia-induced ferroptosis via improving mitochondrial dynamical homeostasis and biogenesis","volume":"308","author":"Wu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib109","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2025.110439_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155365","article-title":"Salidroside pretreatment alleviates ferroptosis induced by myocardial ischemia\/reperfusion through mitochondrial superoxide-dependent AMPKalpha2 activation","volume":"128","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2025.110439_bib111","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.04.035","article-title":"Mapping of mitochondrial ferritin in the brainstem of Macaca fascicularis","volume":"328","author":"Yang","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110439_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102871","article-title":"Mesenchymal stem cell attenuates spinal cord injury by inhibiting mitochondrial quality control-associated neuronal ferroptosis","volume":"67","author":"Yao","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuropharm.2025.110439_bib113","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41419-024-06584-y","article-title":"Metabolism-regulated ferroptosis in cancer progression and therapy","volume":"15","author":"Ye","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2025.110439_bib114","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0006-291X(89)92701-0","article-title":"Liver mitochondrial respiratory functions decline with age","volume":"165","author":"Yen","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110439_bib115","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.parkreldis.2015.05.022","article-title":"Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease","volume":"21","author":"Yoritaka","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2025.110439_bib116","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2016.03.023","article-title":"Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress","volume":"1642","author":"You","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110439_bib117","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbrc.2016.08.034","article-title":"CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2025.110439_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/nu14224886","article-title":"Neurotrophic role of the next-generation probiotic strain L. Lactis mg1363-pMG36e-GLP-1 on Parkinson's disease via inhibiting ferroptosis","volume":"14","author":"Yue","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2025.110439_bib119","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00702-019-01997-y","article-title":"Dopaminergic modulation of striatal function and Parkinson's disease","volume":"126","author":"Zhai","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2025.110439_bib120","article-title":"Melatonin regulates mitochondrial function to alleviate ferroptosis through the MT2\/Akt signaling pathway in swine testicular cells","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825001455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T05:17:55Z","timestamp":1746595075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825001455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":120,"alternative-id":["S0028390825001455"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110439","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson's disease therapy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110439"}}